title: Reversal of left ventricular hypertrophy with different classes of drugs causes differing ventricular biochemical changes.
authors.affiliation: Alton Ochsner Medical Foundation, New Orleans, Lousiana 70121.
authors.forename: M
authors.initials: M
authors.lastname: Arita
authors.forename: S
authors.initials: S
authors.lastname: Horinaka
authors.forename: K
authors.initials: K
authors.lastname: Komatsu
authors.forename: E D
authors.initials: ED
authors.lastname: Frohlich
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000145:classification / Q000494:pharmacology*; D001552:Benzazepines / Q000494:pharmacology; D017272:Celiprolol / Q000494:pharmacology; D003094:Collagen / Q000378:metabolism; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D008297:Male; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D014700:Verapamil / Q000494:pharmacology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001552:Benzazepines; D011506:Proteins; D012313:RNA; D003094:Collagen; D014700:Verapamil; D017272:Celiprolol; C044946:benazepril